Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | IGFBP2 |
| Upstream (Parents) |
|---|
| (<<) ARL4C → IGFBP2 |
| (<<) BCAM → IGFBP2 |
| (<<) CD274 → IGFBP2 |
| (<<) CDKN2A → IGFBP2 |
| (<<) CTPS → IGFBP2 |
| (<<) DISP2 → IGFBP2 |
| (<<) ELF4 → IGFBP2 |
| (<<) EPHB6 → IGFBP2 |
| (<<) FERMT1 → IGFBP2 |
| (<<) FHIT → IGFBP2 |
| (<<) GBP2 → IGFBP2 |
| (<<) HCN2 → IGFBP2 |
| (<<) HLA-A → IGFBP2 |
| (<<) HLA-F → IGFBP2 |
| (<<) IGFBP3 → IGFBP2 |
| (<<) IGFBP4 → IGFBP2 |
| (<<) IRAK1 → IGFBP2 |
| (<<) KRT5 → IGFBP2 |
| (<<) LYNX1 → IGFBP2 |
| (<<) MMP15 → IGFBP2 |
| (<<) MYCN → IGFBP2 |
| (<<) NFIA → IGFBP2 |
| (<<) PKIG → IGFBP2 |
| (<<) PPP3CB → IGFBP2 |
| (<<) SFN → IGFBP2 |
| (<<) SH2D2A → IGFBP2 |
| (<<) STAT2 → IGFBP2 |
| (<<) SUMF1 → IGFBP2 |
| (<<) TCOF1 → IGFBP2 |
| (<<) TNC → IGFBP2 |
| (<<) UBE2L6 → IGFBP2 |
| (<<) YWHAB → IGFBP2 |
| Downstream (Children) |
|---|
| IGFBP2 → CKB (>>) |
| IGFBP2 → IRX2 (>>) |
| IGFBP2 → RHOV (>>) |
| IGFBP2 → TCEB1 (>>) |
